The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Top Cited Papers
- 1 January 2013
- journal article
- review article
- Published by Elsevier BV in Cytotherapy
- Vol. 15 (1), 2-8
- https://doi.org/10.1016/j.jcyt.2012.10.002
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Quantitative Approaches to Detect Donor and Passage Differences in Adipogenic Potential and Clonogenicity in Human Bone Marrow-Derived Mesenchymal Stem CellsTissue Engineering, Part C: Methods, 2012
- Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem CellsMolecular and Cellular Biology, 2012
- Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell Death & Differentiation, 2012
- Expression of blood group genes by mesenchymal stem cellsBritish Journal of Haematology, 2011
- Cell-dose−dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCsExperimental Hematology, 2010
- DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cellsAging Cell, 2010
- Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune EncephalomyelitisMolecular Therapy, 2009
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretionNature, 2009
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006